On March 15, 2018 Actinium Pharmaceuticals, Inc. (NYSE AMERICAN:ATNM) ("Actinium" or "the Company"), reported that it will be attending and presenting at the 28th Annual Oppenheimer Healthcare Conference being held on March 20-21, 2018, at The Westin New York Grand Central in New York City. Details of Actinium’s presentation are as follows (Press release, , 15 15, 2018, View Source [SID1234524821]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Date: Tuesday, March 20, 2018
Time: 1:00 PM ET (subject to changes by the conference organizers)
Room: Track 3
Venue: The Westin New York Grand Central Hotel
Management will conduct 1-on-1 meetings with investors during the conference. To arrange a meeting with Actinium please contact, Steve O’Loughlin, Actinium’s Principal Financial Officer at [email protected].
For more information about the conference, please visit the conference website at the following link: Oppenheimer 28th Annual Healthcare Conference.